Aspiriant LLC
ENB icon

Aspiriant LLC’s Enbridge ENB Stock Holding History

Aspiriant LLC’s Portfolio ENB Stock Details ENB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$310K Buy
6,673
+25
+0.4% +$1.29K 0.01% 315
2026
Q2 		$360K Buy
6,648
+1,211
+22% +$66.4K 0.01% 293
2026
Q1 		$294K Sell
5,437
-353
-6% -$18K 0.01% 278
2025
Q4 		$277K Buy
5,790
+353
+6% +$16.9K 0.01% 286
2025
Q3 		$274K Hold
5,437
– – 0.01% 264
2025
Q2 		$246K Hold
5,437
– – 0.01% 282
2025
Q1 		$241K Hold
5,437
– – 0.01% 266
2024
Q4 		$231K Hold
5,437
– – 0.01% 265
2024
Q3 		$221K Buy
+5,437
New +$209K 0.01% 268
2023
Q3 		– Sell
-5,437
Closed -$202K – 287
2023
Q2 		$202K Hold
5,437
– – 0.01% 273
2023
Q1 		$207K Hold
5,437
– – 0.01% 266
2022
Q4 		$213K Hold
5,437
– – 0.01% 253
2022
Q3 		$201K Sell
5,437
-140
-3% -$5.9K 0.01% 253
2022
Q2 		$236K Sell
5,577
-1,689
-23% -$75.4K 0.01% 240
2022
Q1 		$335K Hold
7,266
– – 0.02% 214
2021
Q4 		$283K Buy
+7,266
New +$291K 0.02% 233
2020
Q2 		– Sell
-7,238
Closed -$210K – 184
2020
Q1 		$210K Sell
7,238
-3,158
-30% -$117K 0.02% 175
2019
Q4 		$414K Sell
10,396
-113
-1% -$4.22K 0.04% 151
2019
Q3 		$370K Sell
10,509
-5,558
-35% -$192K 0.03% 165
2019
Q2 		$581K Sell
16,067
-1,574
-9% -$57.3K 0.05% 139
2019
Q1 		$641K Sell
17,641
-9,397
-35% -$339K 0.05% 133
2018
Q4 		$844K Sell
27,038
-1,679
-6% -$54K 0.06% 116
2018
Q3 		$929K Sell
28,717
-1,448
-5% -$50.6K 0.08% 112
2018
Q2 		$1.08M Buy
30,165
+2,532
+9% +$80.2K 0.09% 104
2018
Q1 		$870K Buy
+27,633
New +$967K 0.08% 115
2017
Q4 		– Sell
-32,872
Closed -$1.38M – 110
2017
Q3 		$1.38M Sell
32,872
-10,383
-24% -$422K 0.12% 92
2017
Q2 		$1.72M Sell
43,255
-2,763
-6% -$111K 0.15% 82
2017
Q1 		$1.92M Buy
+46,018
New +$1.94M 0.16% 85

Other funds holding ENB

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Addenda Capital
Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
QV Investors
QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
Midwest Trust
Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return
Verity & Verity
Verity & Verity Beaufort, South Carolina $1.5B AUM 28.12% 1-Year Est. Return

Aspiriant LLC's ENB Position: Q3 2026 in Review

Aspiriant LLC increased its Enbridge (ENB) stake by 0.38% in Q3 2026, buying an estimated $1.29K and bringing the position to 6,673 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #315.

Aspiriant LLC first reported a position in ENB in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.92M in Q1 2017. 390 funds tracked by Wall St. Rank hold ENB as of Q3 2026.

  • Aspiriant LLC held 6,673 shares of Enbridge worth $310K as of Q3 2026.
  • Aspiriant LLC bought 25 Enbridge shares in Q3 2026, an estimated $1.29K.
  • Enbridge made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #315 holding.
  • Aspiriant LLC first reported a position in Enbridge in Q1 2017 and has held it in 28 quarters since.
  • Aspiriant LLC's Enbridge position peaked at $1.92M in Q1 2017.
  • 390 funds tracked by Wall St. Rank held Enbridge as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.